Delin Ventures

Delin Ventures

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Athernal Bio launches with £3.5m in funding from Delin Ventures to develop therapies for blood cancer precursor conditions

Athernal Bio launches with £3.5m in funding from Delin Ventures to develop therapies for blood cancer precursor conditions

Athernal Bio launches with £3.5m in funding from Delin Ventures to develop therapies for blood cancer precursor conditions

Athernal Bio is developing immunotherapies for clonal haematopoiesis, aiming to stop blood cancers before they develop in high-risk patients.

Delin Ventures

More venture news

Openmoove
16 Apr 2026
Openmoove lands £700k in funding led by Development Bank of Wales to streamline property transaction workflows
EquityProperty
The Little Loop
15 Apr 2026
The Little Loop secures £750k in funding from The FSE Group for B2B2C clothing trade-in and resale platform
EquityCommerce
Ascension
15 Apr 2026
Ascension secures £1.7m in funding from UKI2S and Innovate UK to tap geothermal critical mineral reserves
EquityIndustrial